跳至主要内容
临床试验/ACTRN12607000561482
ACTRN12607000561482已完成未知

A double-blind randomised controlled trial of FENO guided asthma therapy and clinical guideline guided asthma therapy in pregnant women with asthma to reduce asthma exacerbations

Hunter New England Health0 个研究点目标入组 210 人开始时间: 2007年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
210

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • 12-20 weeks gestation
  • Doctor diagnosis of asthma
  • Symptoms of asthma or taken treatment for asthma in the last 12 months

排除标准

  • Concomittent chronic medical illness,
  • chronic lung disease other than asthma, drug or alcohol dependence,
  • inability to attend study visits,
  • inability to perform spirometry,
  • >3 courses of oral corticoseroids (OCS) in past year,
  • Hospital admission for an asthma exacerbation in the past 3 months,
  • on regular oral prednisolone or theophylline

研究者

发起方
Hunter New England Health

相似试验

Managing Asthma in Pregnancy (MAP) Study | 临床试验